
The German government on Tuesday expressed "great concern" over the Israeli parliament's decision to introduce the death penalty for convicted terrorists.
"Understandably, Israel has taken a hard line against terrorism since October 7," said government spokesman Stefan Kornelius in Berlin. "However, the German government views the law passed yesterday with great concern."
Opposition to the death penalty is a fundamental feature of German policy, he said.
The German government is also concerned that such a law "would likely apply exclusively to Palestinians in the Palestinian territories," Kornelius added. "It therefore regrets the Knesset’s decision and cannot endorse it."
The Knesset, Israel's parliament, approved the bill on Monday. It provides that the death penalty or life imprisonment may be imposed for terrorist-motivated murder with the aim of destroying the State of Israel.
Israel abolished the death penalty for murder in 1954 and retained it only in exceptional cases. The execution of the German Nazi criminal Adolf Eichmann in 1962 was the last carried out in Israel.
LATEST POSTS
- 1
IDF finds weapon of slain hostage Capt. Daniel Perez in booby-trapped Gaza compound - 2
Financial plan Cordial Home Redesigns That Add Worth - 3
Katz, IDF: We assassinated IRGC intelligence chief Majid Khademi - 4
Steinmeier honours Italian 'guest workers' who rebuilt German economy - 5
A somber Thor is returning for 'Avengers: Doomsday': Watch the dread-filled teaser
Russia provided Iran with list of Israeli energy targets, Ukrainian intelligence finds
Zelensky confidant dismissed from further posts amid bribery scandal
WHO issues guidance on GLP-1 drugs for obesity
Addiction-stricken community struggles to keep a syringe program going after Trump's order
75% of US adults may meet criteria for obesity under new definition, study finds
Chinese mega embassy could bring security advantages, says No 10
Holyvolt And Wildcat Could Help The West Reclaim Battery Leadership
Manual for extravagance SUVs for seniors
Baby takes 1st steps after receiving groundbreaking gene-edited therapy













